Early-stage returns?
- PMID: 17093473
- DOI: 10.1038/nbt1106-1335
Early-stage returns?
Abstract
Contrary to conventional thinking, there are compelling reasons for investors to consider early-stage life science ventures, especially in the context of a maturing biotech business 'ecosystem'.
MeSH terms
LinkOut - more resources
Full Text Sources
